Prediction of the Carcinogenic Potential of Human Pharmaceuticals Using Repeated Dose Toxicity Data and Their Pharmacological Properties (original ) (raw )Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals
J. Contrera
Regulatory Toxicology …, 1997
View PDFchevron_right
Prediction of 2-Year Carcinogenicity Study Results for Pharmaceutical Products: How Are We Doing?
abby jacobs
Toxicological Sciences, 2005
View PDFchevron_right
Third Chronological Supplement to the Carcinogenic Potency Database: Standardized Results of Animal Bioassays
Thomas Slone
2013
View PDFchevron_right
Which drugs cause cancer? * Cancer bioassays
Andrew Knight
BMJ, 2005
View PDFchevron_right
Key characteristics of 86 agents known to cause cancer in humans
Mustafa Al-Zoughool
Journal of Toxicology and Environmental Health, Part B, 2019
View PDFchevron_right
Supplement to the Carcinogenic Potency Database (CPDB): Results of Animal Bioassays Published in the General Literature in 1993 to 1994 and by the National Toxicology Program in 1995 to 1996
Neela Manley
Environmental Health Perspectives, 1999
View PDFchevron_right
The Carcinogenic Potency Database: analyses of 4000 chronic animal cancer experiments published in the general literature and by the U.S. National Cancer Institute/National Toxicology Program
Neela Manley
Environmental Health Perspectives, 1991
View PDFchevron_right
Target Organs in Chronic Bioassays of 533 Chemical Carcinogens
Leslie Bernstein
Environmental Health Perspectives, 1991
View PDFchevron_right
Carcinogenicity Testing of Pharmaceuticals in the European Union: A Workshop Report
Beatriz Silva Lima
Drug Information Journal, 2000
View PDFchevron_right
Human carcinogenic risk evaluation, Part III: Assessing cancer hazard and risk in human drug development
abby jacobs
Toxicological sciences : an official journal of the Society of Toxicology, 2004
View PDFchevron_right
The fifth plot of the Carcinogenic Potency Database: results of animal bioassays published in the general literature through 1988 and by the National Toxicology Program through 1989
Neela Manley
Environmental Health Perspectives, 1993
View PDFchevron_right
Third chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December 1986 and by the National Toxicology Program through June 1987
Thomas Slone
Environmental Health Perspectives, 1990
View PDFchevron_right
Second chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1984 and by the National Toxicology Program through May 1986
Peggy A. Lopipero-Langmo
Environmental Health Perspectives, 1987
View PDFchevron_right
Carcinogenicity of Biopharmaceuticals
Jan Willem van der Laan
Genotoxicity and Carcinogenicity Testing of Pharmaceuticals, 2015
View PDFchevron_right
Current status and use of short/medium term models for carcinogenicity testing of pharmaceuticals--scientific perspective
Jan Willem van der Laan
Toxicology letters, 2000
View PDFchevron_right
Preclinical toxicology of anticancer agents
Philip Schein
Cancer research, 1977
View PDFchevron_right
Association between Carcinogenic Potency and Tumor Pathology in Rodent Carcinogenesis Bioassays
Leslie Bernstein
Toxicological Sciences, 1986
View PDFchevron_right
Association between carcinogenic potency and tumor pathology in rodent carcinogenesis bioassays*1
Bonnie R Stern, PhD, MPH
Fundamental and Applied Toxicology, 1986
View PDFchevron_right
Compendium of Chemical Carcinogens by Target Organ: Results of Chronic Bioassays in Rats, Mice, Hamsters, Dogs, and Monkeys
Thomas Slone
Toxicologic Pathology, 2001
View PDFchevron_right
Quantitative Correlation with Carcinogenic Potency of Different Short Term Tests
Leonardo Santi
Toxicologic Pathology, 1984
View PDFchevron_right
Carcinogenicity Assessments of Biotechnology-Derived Pharmaceuticals: A Review of Approved Molecules and Best Practice Recommendations
R. Steigerwalt
Toxicologic Pathology, 2010
View PDFchevron_right
Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans
Yann Grosse
Journal of Toxicology and Environmental Health, Part B, 2019
View PDFchevron_right
Estimates of the proportion of chemicals that were carcinogenic or anticarcinogenic in bioassays conducted by the National Toxicology Program
Cynthia Van Landingham
Environmental Health Perspectives, 1999
View PDFchevron_right
Sixth plot of the carcinogenic potency database: results of animal bioassays published in the General Literature 1989 to 1990 and by the National Toxicology Program 1990 to 1993
Bonnie R Stern, PhD, MPH , Neela Manley , Thomas Slone
Environmental Health Perspectives, 1995
View PDFchevron_right
A Retrospective Evaluation of COMPACT Predictions of the Outcome of NTP Rodent Carcinogenicity Testing
Costas Ioannides
Environmental Health Perspectives, 1995
View PDFchevron_right
Veterinary Drugs No Longer Need Testing for Carcinogenicity in Rodent Bioassays
D. Galer
Regulatory Toxicology and Pharmacology, 1998
View PDFchevron_right
How accurate is in vitro prediction of carcinogenicity?
Nicholas Billinton , Richard Walmsley
British Journal of Pharmacology, 2011
View PDFchevron_right
Regulatory requirements and ICH guidelines on carcinogenicity testing of pharmaceuticals: A review on current status
Gopabandhu Jena
Indian Journal of Pharmacology, 2005
View PDFchevron_right
New clues on carcinogenicity.pdf
Giuseppina C Gini , Alessandra Roncaglioni
View PDFchevron_right
The in Vivo Rodent Test Systems for Assessment of Carcinogenic Potential
Jan-Willem van der Laan
Regulatory Toxicology and Pharmacology, 2002
View PDFchevron_right